Merck & Co.
2000 Galloping Hill Road
Kenilworth, NJ 07033 U.S.A.
To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive bio pharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future. Our core values are driven by a desire to improve life, achieve scientific excellence, operate with the highest standards of integrity, expand access to our products and employ a diverse workforce that values collaboration.
The product websites presented here are intended for use in the United States, its territories and Puerto Rico only. Other countries may have different regulatory requirements and review practices that may require referencing different information. If you are a resident of a country other than the United States, please select WORLDWIDE at the top of the page to find information about our offices around the globe. Merck and its legacy companies have been working to discover and develop vaccines for more than a century. Our unique vaccines have helped prevent a number of diseases, including ones never thought preventable. Today, we remain dedicated to the complex business of researching and producing vaccines.
Whether it’s helping invent the next breakthrough treatment or simply challenging and supporting one another for mutual betterment, our culture is about applied curiosity. We are dedicated to our team members’ growth and development, and empower each of them to reach their full potential regardless of function, geography or experience level.
WHY MERCK? Because we recognize that our people are critical to our mission of improving and saving lives and are committed to rewarding their contributions. And, that’s why we provide a valuable suite of compensation and benefit programs as well as resources to support our employees’ professional achievement and personal well-being. Together, we call these “Total Rewards.”
Julie Gerberding, M.D., M.P.H. executive vice president & chief patient officer, Strategic Communications, Global Public Policy and Population Health
From AIDS to Zika, Ebola to SARS, Julie Gerberding has long been at the forefront of many of the world’s most pressing population health issues. Throughout her impressive career, the former director of the U.S. CDC and Merck’s newly named Chief Patient Officer has been driven by one thing – a passion for improving health and making a difference in people’s lives.
Julie joined Merck in 2010 as president of Merck Vaccines where she helped to globalize the company’s vaccines business. In December 2014, Julie took on a new leadership role, joining Merck’s Executive Committee as executive vice president, Strategic Communications, Global Public Policy and Population Health; and in June 2016, she added another responsibility to her growing list of achievements: Chief Patient Officer.
Corporate governance structures are established to make sure corporations are accountable to their owners—the shareholders.
Our corporate governance goes beyond the company’s relationship to our shareholders, because it reflects our relationship to society, and issues that matter to our key stakeholders can very quickly become important issues for our shareholders. As such, our objective is to balance fiduciary duty and accountability to generate long-term shareholder value, while also considering, in a transparent manner, the concerns of other stakeholders.
Krebs Biochemicals & Industries Limited
click above to visit
this company / organization